A Phase 1 Crossover Trial Evaluating the Pharmacokinetics of Tenofovir Reduced-Glycerin 1% Gel in the Rectal and Vaginal Compartments in Women

Trial Profile

A Phase 1 Crossover Trial Evaluating the Pharmacokinetics of Tenofovir Reduced-Glycerin 1% Gel in the Rectal and Vaginal Compartments in Women

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Jul 2015

At a glance

  • Drugs Tenofovir (Primary) ; Tenofovir (Primary)
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Sponsors CONRAD
  • Most Recent Events

    • 22 Jul 2015 Results presented at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention.
    • 16 Apr 2015 Status changed from not yet recruiting to completed, according to to ClinicalTrials.gov record.
    • 26 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top